title: A comparison of the effects of IGF-I and insulin on glucose metabolism, fat metabolism and the cardiovascular system in normal human volunteers.
abstract: The metabolic and cardiovascular effects of recombinant human IGF-I were compared to insulin in six normal subjects. Subjects were studied twice and intravenously received an infusion of [6,6-2H2]glucose (0-480 min) and in random order either IGF-I 20 micrograms kg-1 h-1 (43.7 pmol kg-1 min-1 or insulin 0.5 mU kg-1 min-1 (3.4 pmol kg-1 min-1) with an euglycaemic clamp. One subject was withdrawn following a serious adverse event. During the IGF-I infusion glucose appearance rate (Ra) decreased from 1.79 +/- 0.13 at baseline (150-180 min) to 0.35 +/- 0.26 mg kg-1 min-1 (P < 0.01) at 360 min, and glucose utilization rate (Rd) increased from 1.79 +/- 0.28 to 4.17 +/- 0.84 mg kg-1 min-1 (P < 0.01). There was no change in free fatty acids (FFA) and an increase (percentage change from pre-infusion mean) in cardiac output +l37.3% +/- 9% (P < 0.01), heart rate +13% +/- 2% (P < 0.01) and stroke volume +21% +/- 7% (P < 0.05). During the insulin infusion glucose Ra decreased from 1.89 +/- 0.13 to 0.34 +/- 0.33 mg kg-1 min-1 (P < 0.01) and FFA from 0.546 mmol l-1 to 0.198 mmol l-1 (P < 0.01), glucose Rd increased from 1.89 +/- 0.18 to 5.41 +/- 1.47 mg kg-1 min-1 (P < 0.01) and there were no significant changes in the cardiovascular variables.
authors.affiliation: Division of Medicine, United Medical and Dental School, Guy's Hospital, London, UK.
authors.forename: D L
authors.initials: DL
authors.lastname: Russell-Jones
authors.forename: A T
authors.initials: AT
authors.lastname: Bates
authors.forename: A M
authors.initials: AM
authors.lastname: Umpleby
authors.forename: T R
authors.initials: TR
authors.lastname: Hennessy
authors.forename: S B
authors.initials: SB
authors.lastname: Bowes
authors.forename: K D
authors.initials: KD
authors.lastname: Hopkins
authors.forename: N
authors.initials: N
authors.lastname: Jackson
authors.forename: J
authors.initials: J
authors.lastname: Kelly
authors.forename: F
authors.initials: F
authors.lastname: Shojaee-Moradie
authors.forename: R H
authors.initials: RH
authors.lastname: Jones
mesh_terms: D000328:Adult; D005223:Fats / Q000378:metabolism*; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005947:Glucose / Q000378:metabolism*; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D007328:Insulin / Q000494:pharmacology*; D007334:Insulin-Like Growth Factor I / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged
chemical_list: D005223:Fats; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D007334:Insulin-Like Growth Factor I; D005947:Glucose